Quantum Support Vector Machines In Prostate Cancer Detection
Quantum SVMs
Recent studies show that Quantum Machine Learning (QML) techniques, particularly Quantum Support Vector Machines (QSVMs), can improve disease detection, especially in complex and unbalanced healthcare datasets. In datasets for diabetes, heart failure, and prostate cancer, quantum models outperform conventional machine learning methods in key areas.
Modern medicine struggles to accurately and earlyly diagnose diseases. Unbalanced datasets in medicine, where there are often many more positive examples than negative cases, are a key impediment. This imbalance makes standard machine learning algorithms perform worse. Scientists are investigating whether quantum computing, which uses entanglement and superposition, can improve pattern recognition in these tough scenarios.
A comparative analysis by Tudisco et al. and published by Quantum Zeitgeist compared QNNs and QSVMs to classical algorithms like Logistic Regression, Decision Trees, Random Forests, and classical SVMs. Quantum methods were tested on prostate cancer, heart failure, and diabetic healthcare datasets to overcome unbalanced data.
QSVMs outperform QNNs and classical models on all datasets. This suggests quantum models excel at difficult categorisation problems. This superiority was notably evident in datasets with significant imbalance, a common healthcare issue. The Heart Failure dataset is severely imbalanced, and standard methods often fail to achieve high recall. Quantum models did better. Quantum models, particularly QSVMs, performed better at detecting positive examples (high recall) in these situations, implying improved diagnosis accuracy in complex clinical scenarios. Quantum models look more beneficial with class difference.
QNNs had good precision scores but overfitted training data, limiting their usefulness. Overfitting occurs when a model learns the training data too well and catches noise and features instead of essential patterns, reducing generalisation performance on unseen data. However, QSVMs were more resilient and reliable. QSVM's high recall across all datasets shows its ability to dependably identify positive cases in various clinical scenarios. Avoiding overfitting in QNNs may require studying alternate circuit design and hyperparameter tuning.
A study called “Quantum Support Vector Machine for Prostate Cancer Detection: A Performance Analysis” examined how QSVM could improve prostate cancer detection over regular SVM. Early identification improves prostate cancer treatment and results. Classical SVMs increase biomedical data interpretation, but large, high-dimensional datasets limit them. QSVMs, which use quantum notions like superposition and entanglement, can manage multidimensional data and speed up operations.
The prostate cancer technique used the Kaggle Prostate Cancer Dataset, which initially comprised 100 observations with 9 variables, including clinical and diagnostic data. The dataset's initial class imbalance was corrected using RandomOverSampler during preparation. The data was normalised and normalised using MinMaxScaler and StandardScaler to increase feature comparability and prepare for quantum encoding. Oversampled to 124 samples, processed data was divided into training (80%) and testing (20%) subsets.
The QSVM approach relied on a quantum feature map architecture, the ZZFeatureMap with full entanglement, carefully selected and tested to match the dataset. This feature map encodes conventional data into quantum states, allowing the quantum system to express complex data correlations in high-dimensional regions using entanglement. QSVM estimates the inner product (overlap) of quantum states that represent data points to generate the kernel function for SVM classification. This estimator measures the likelihood of witnessing the starting state using a quantum circuit.
Prostate cancer experiments provide compelling evidence:
Kernel matrix analysis revealed different patterns. The RBF kernel of the classical SVM showed high similarity values across data points, suggesting a strongly connected feature space. However, QSVM's ZZFeatureMap produced a more dispersed feature space with fewer high off-diagonal values. This implies that the quantum feature space's unique properties boosted class distinguishability.
QSVM outperformed classical SVM (87.89% accuracy, 85.42% sensitivity) on the training dataset with 100% accuracy and sensitivity. As shown, the quantum feature map distinguishes classes without overlap during training.
On the test dataset, both models were 92% accurate. QSVM surpassed SVM in essential medical diagnostic measures, with 100% sensitivity and 93.33% F1-Score on test data, compared to 92.86% and 92.86% for SVM.
Importantly, the QSVM model had no False Negatives (missing malignant cases) in the test data. Only one False Negative occurred in the SVM model. QSVM's great sensitivity is vital in medical circumstances when a false negative could lead to an ailment going undiagnosed and untreated. Quantum feature mapping increases class separation and allows more complex representations.
Cross-validation studies demonstrated that the SVM model was more stable across data subsets than the QSVM, suggesting that the QSVM model overfitted to the training data despite its great performance on the test set. We discuss how QSVM's improved sensitivity and F1-Score aid medical diagnosis. Quantum feature mapping's ability to create a unique, dispersed feature space, especially when separating complex data points, improves performance. QSVM was used to categorise prostate cancer datasets for the first time.
